Home > Boards > US Listed > Biotechs > Adamis Pharmaceuticals Corporation (ADMP)

Adamis Pharma prices public offering of 3.72 mln

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mlkrborn Member Profile
 
Followed By 39
Posts 7,816
Boards Moderated 1
Alias Born 01/04/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 4:51:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 4:44:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/20/2020 4:38:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/20/2020 4:35:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/20/2020 4:32:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 5:25:19 PM
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI GlobeNewswire Inc. - 11/16/2020 6:45:00 AM
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update GlobeNewswire Inc. - 11/9/2020 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 4:26:24 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 4:18:13 PM
Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business Update GlobeNewswire Inc. - 11/5/2020 9:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/14/2020 5:14:09 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 10/5/2020 5:31:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/5/2020 5:27:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2020 4:28:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2020 6:35:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2020 6:34:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2020 4:53:49 PM
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 9/18/2020 9:00:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/17/2020 4:23:15 PM
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 9/17/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 4:22:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 5:21:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 4:29:20 PM
Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders GlobeNewswire Inc. - 9/3/2020 4:05:10 PM
mlkrborn   Friday, 12/13/13 10:56:43 AM
Re: [SMART MONEY] post# 348
Post # of 2293 
Adamis Pharma prices public offering of 3.72 mln shares of common stock at $5.95 per share; announces listing on NASDAQ, reverse stock split (ADMP) : In connection with the offering, Adamis has completed a 1-for-17 reverse stock split of its common stock which is effective as of December 13, 2013. The common stock began trading, on a split-adjusted basis, on The NASDAQ Capital Market under the symbol "ADMP" on December 13, 2013. In connection with its listing on The NASDAQ Capital Market, the company's common stock will cease trading on the OTC QB.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences